What Is Neuroleptic Malignant Syndrome (NMS)?

Neuroleptic malignant syndrome (NMS) is a rare, life-threatening reaction to certain medications that block dopamine in the brain, most commonly antipsychotic drugs. It causes dangerously high fever, severe muscle rigidity, confusion, and unstable heart rate and blood pressure. Symptoms typically develop over one to three days and require emergency medical treatment.

What Causes NMS

Dopamine is a chemical messenger that helps regulate body temperature, muscle movement, and consciousness. Antipsychotic medications (also called neuroleptics) work by reducing dopamine activity in the brain. In NMS, this dopamine blockade triggers a cascade of dysfunction: muscles lock up, the body’s internal thermostat fails, and the nervous system loses its ability to regulate basic functions like heart rate and blood pressure.

NMS most often occurs after starting or increasing the dose of an antipsychotic, but it can also happen when someone abruptly stops taking a dopamine-boosting medication used for Parkinson’s disease. Onset averages 4 to 14 days after starting therapy, and 90% of cases appear within the first 10 days. That said, NMS can develop even years into treatment. Once it begins, it usually escalates over 24 to 72 hours.

The Four Cardinal Symptoms

NMS produces four hallmark problems that tend to appear together:

  • Severe muscle rigidity. Muscles become extremely stiff, sometimes described as “lead pipe” rigidity because the limbs resist movement in every direction. This rigidity can be intense enough to cause muscle breakdown (rhabdomyolysis), releasing proteins into the bloodstream that can damage the kidneys.
  • High fever. Body temperature rises above 38°C (100.4°F) and can climb much higher. Unlike a fever from infection, this heat comes from the muscles themselves contracting continuously.
  • Altered mental status. This ranges from confusion and agitation to drowsiness and, in severe cases, unresponsiveness. The person may seem “not themselves” well before the full picture emerges.
  • Autonomic instability. The part of the nervous system that controls automatic functions goes haywire. Heart rate speeds up, blood pressure swings between dangerously high and dangerously low, breathing becomes rapid, and heavy sweating is common.

All four features are typically present for a diagnosis. Additional neurologic signs such as tremor, difficulty swallowing, and slurred speech can also appear.

Who Is at Higher Risk

Anyone taking a dopamine-blocking medication can develop NMS, but certain factors raise the odds. Dehydration is a significant risk, as is physical exhaustion, agitation, or being in a hot environment. Rapid dose increases and high-potency antipsychotic medications also make the syndrome more likely. People who have had NMS before face a meaningful chance of it happening again if they restart antipsychotic treatment, though careful reintroduction under close monitoring can reduce that risk.

How NMS Is Diagnosed

There is no single blood test or scan that confirms NMS. Diagnosis is clinical, meaning doctors piece it together from the combination of symptoms plus a history of dopamine-blocking medication use (or recent withdrawal from a dopamine-boosting drug). The DSM-5 criteria require exposure to a dopamine antagonist or withdrawal from a dopamine agonist within the past 72 hours, along with high fever and heavy sweating.

Lab tests still play an important role, mainly to detect complications. Creatine kinase, an enzyme released when muscle fibers break down, is elevated in 50 to 100% of NMS cases and serves as a marker of muscle damage severity. White blood cell counts are elevated in 70 to 98% of cases. Doctors also check kidney function, electrolytes (potassium and calcium levels often shift as muscles break down), and urine for signs of rhabdomyolysis. Brain imaging and spinal fluid analysis may be ordered to rule out other causes like infection or stroke.

How NMS Differs From Serotonin Syndrome

Serotonin syndrome is another drug reaction that also causes fever, altered mental status, and muscle problems, but it stems from too much serotonin activity rather than dopamine blockade. The physical exam differences are distinctive. NMS produces rigid, stiff muscles throughout the body with reduced reflexes. Serotonin syndrome causes increased muscle tone concentrated in the lower limbs, exaggerated reflexes, and clonus, a pattern of involuntary rhythmic jerking, especially at the ankles. Serotonin syndrome also tends to come on faster, often within hours of a medication change, while NMS develops over days. Knowing which medications were involved is the fastest way to tell them apart: antipsychotics point to NMS, while antidepressants and other serotonin-boosting drugs point to serotonin syndrome.

Treatment and Recovery

NMS is a medical emergency. The first and most critical step is stopping the offending medication immediately. From there, treatment focuses on supporting the body through the crisis: cooling measures for dangerously high temperatures, aggressive fluids to protect the kidneys from muscle breakdown products, and careful monitoring of heart rhythm and blood pressure.

When muscle rigidity is severe, medications that directly relax the muscles by blocking calcium release within muscle cells may be used, with most patients responding to moderate doses. Medications that mimic dopamine can sometimes help restore balance in the brain. Sedatives from the benzodiazepine family are often given to control agitation and may have a direct therapeutic benefit. In refractory cases that don’t respond to these measures, electroconvulsive therapy has been used to help normalize temperature and consciousness.

With early recognition and aggressive supportive care, most people survive NMS and recover fully. The syndrome typically resolves within one to two weeks once the triggering medication is cleared from the body, though long-acting injectable antipsychotics can prolong the timeline because the drug stays in the system longer. The most dangerous complications are kidney failure from rhabdomyolysis, respiratory failure, cardiac arrest, and blood clots from prolonged immobility. Historically, NMS carried a mortality rate above 20%, but with modern intensive care and earlier detection, that number has dropped substantially.

Restarting Antipsychotic Medication After NMS

For many people who experience NMS, the underlying condition that required antipsychotic treatment hasn’t gone away. Restarting medication is possible but requires caution. Most guidelines recommend waiting at least two weeks after NMS has fully resolved before reintroducing any antipsychotic, choosing a lower-potency option than the one that triggered the episode, starting at the lowest possible dose, and increasing slowly. Close monitoring during this period is essential, because roughly 30% of patients who are rechallenged with an antipsychotic develop NMS again if precautions aren’t taken carefully.